- Home
- UCTT vs BCRX Comparison
UCTT vs BCRX Comparison
Compare UCTT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UCTT | BCRX |
|---|---|---|
| Founded | 1991 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | UCTT | BCRX |
|---|---|---|
| Price | $58.90 | $9.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $75.00 | $20.82 |
| AVG Volume (30 Days) | 1.4M | ★ 6.4M |
| Earning Date | 04-27-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $1,734,500,000.00 | $25,186,000.00 |
| Revenue This Year | $19.18 | N/A |
| Revenue Next Year | $17.36 | $12.55 |
| P/E Ratio | ★ N/A | $7.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.66 | $6.00 |
| 52 Week High | $73.80 | $11.31 |
Technical Indicators
Market Signals| Indicator | UCTT | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 62.83 |
| Support Level | $23.13 | $7.85 |
| Resistance Level | $58.70 | $10.32 |
| Average True Range (ATR) | 3.96 | 0.58 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 32.10 | 58.06 |
Price Performance
Historical ComparisonAbout UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.